|Last Price$54.21||Day Change (%)-0.42%|
|Open Price$54.23||Day Change ($)-0.23|
|Day Range53.84–55.00||52-Week Range42.43–59.60|
As of Fri 01/23/2015 05:11 PM EST | USD
Mylan Launches Generic Diovan® Tablets
South African National Department of Health Selects Mylan as a Leading Supplier for 2015/2018 Antiretroviral Tender
Mylan Laboratories MYL reported impressive second-quarter results Wednesday. However, most of the improvement was temporary and will not affect our fair value estimate. The quarter was only slightly better than we expected after excluding a one-time litigation payment and proceeds from a product ...
Supreme Court Sides With Teva in Patent Case on Copaxone
Declining fuel prices stoked great returns at several of these companies, but that's not a lasting advantage.
Anthera Pharmaceuticals Announces Appointment of Klara A. Dickinson as Senior Vice President, Chief Regulatory Officer
Plus, a top executive bolts from eBay, Brazilian telcos get cheap, and more.
These mutual funds have far more than their recent success going for them.
As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.
Corporate credit spreads are fairly valued--albeit at the tight end of the range that we view as fairly valued.